Jeremy Cooper Appendix 3Y Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/9/2001. Name of entity Select Vaccines Limited ABN 25 062 063 692 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. Name of Director Jeremy Cooper Date of last notice 4 July 2003 Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part. Direct or indirect interest Direct and Indirect Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. Director Related Entity Date of change 7 August 2003 Direct Indirect Shares - 197,500 No. of securities held prior to change Options (SLTO) - 250,000 Options (SLTOA) 750,000 67,500 Class Ordinary Shares & Options Direct Indirect Shares - - Number acquired Options (SLTO) - - Options (SLTOA) - - Direct Indirect Shares - - Number disposed Options (SLTO) - (50,000) Options (SLTOA) - - Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation Sale on market @ $0.10 Direct Indirect Shares - 197,500 No. of securities held after change Options (SLTO) - 200,000 Options (SLTOA) 750,000 67,500 Nature of change Example: on-market trade, offmarket trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back On market sale
SLT Price at posting:
0.0¢ Sentiment: None Disclosure: Held